首页> 外国专利> TREATMENT OF TYPE I DIABETES MELLITUS (T1DM) IN YOUNG NEWLY DIAGNOSED PATIENTS

TREATMENT OF TYPE I DIABETES MELLITUS (T1DM) IN YOUNG NEWLY DIAGNOSED PATIENTS

机译：新诊断年轻患者的I型糖尿病（T1DM）的治疗

页面导航

摘要
著录项
相似文献

摘要

Provided is treatment of young (about 5 to 18 year old) patients with newly diagnosed type I diabetes mellitus (TIDM) by treating them with a DNA vector encoding an autoantigen associated with TIDM, including repeated administration (e.g. weekly administration) of the plasmid for an extended dosing duration (e.g. for at least about 52 weeks). Articles of manufacture for use in the claimed methods are also disclosed.

机译：通过用编码与TIDM相关的自身抗原的DNA载体治疗新诊断的I型糖尿病（TIDM）的年轻（约5至18岁）患者，包括重复施用（例如每周施用）质粒来治疗。延长给药时间（例如至少约52周）。还公开了用于所要求保护的方法的制品。

著录项

公开/公告号WO2012015903A1

专利类型
公开/公告日2012-02-02

原文格式PDF
申请/专利权人 BAYHILL THERAPEUTICS INC.;GARREN HIDEKI;SOLVASON NANETTE;VALONE FRANK;TINGLEY WHITTEMORE G.;
展开▼

申请/专利号WO2011US45512
发明设计人 GARREN HIDEKI;SOLVASON NANETTE;VALONE FRANK;TINGLEY WHITTEMORE G.;
展开▼

申请日2011-07-27
分类号A61K48;A61K38;A61K38/28;A61P3/10;A61P7/12;
国家 WO
入库时间 2022-08-21 17:17:58

相似文献

专利
外文文献
中文文献